Microglia/macrophages promote glioma progression
暂无分享,去创建一个
[1] M. Luczak,et al. Tuftsin induced tumor necrosis activity , 1987, Molecular and Cellular Biochemistry.
[2] C. Siao,et al. Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II , 2002, The Journal of Neuroscience.
[3] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[4] F. Heppner,et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion , 2009, Proceedings of the National Academy of Sciences.
[5] A. Wesołowska,et al. Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor , 2008, Oncogene.
[6] Brian D. Ross,et al. Experimental Gliosarcoma Induces Chemokine Receptor Expression in Rat Brain , 2000, Experimental Neurology.
[7] S. Thanos,et al. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] I. Siemion,et al. Tuftsin: On the 30-year anniversary of Victor Najjar’s discovery , 1999, Peptides.
[9] R. Nitsch,et al. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1 , 2001, Nature Cell Biology.
[10] D. Constam,et al. Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. , 1992, Journal of immunology.
[11] S. Tsirka,et al. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus , 1998, Current Biology.
[12] W. Roa,et al. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation , 2002, Acta Neuropathologica.
[13] H. Kettenmann,et al. Secondary Lymphoid Tissue Chemokine (CCL21) Activates CXCR3 to Trigger a Cl− Current and Chemotaxis in Murine Microglia1 , 2002, The Journal of Immunology.
[14] M. Esiri,et al. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease 1. Gliomas , 1991, Journal of the Neurological Sciences.
[15] E. Ranheim,et al. Tumoricidal Effects of Activated Macrophages in a Mouse Model of Chronic Lymphocytic Leukemia1 , 2009, The Journal of Immunology.
[16] Melody A Swartz,et al. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. , 2007, Cancer cell.
[17] S. Futaki,et al. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. , 1987, The Journal of biological chemistry.
[18] P. Allavena,et al. The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance , 2008, Immunological reviews.
[19] M. Luczak,et al. Suppression of Friend virus-induced leukaemia in mice by tuftsin. , 1986, The Journal of general virology.
[20] F. D. De Braud,et al. Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] T. Marunouchi,et al. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. , 1993, Journal of immunology.
[22] M. Graeber,et al. Microglia only weakly present glioma antigen to cytotoxic T cells , 1999, International Journal of Developmental Neuroscience.
[23] A. Sauter,et al. Ischemia‐induced neuronal expression of the microglia attracting chemokine secondary lymphoid‐tissue chemokine (SLC) , 2001, Glia.
[24] P. Allavena,et al. Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production. , 2005, Cancer research.
[25] Zhijin Wu,et al. Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma , 2008, Molecular Cancer Therapeutics.
[26] Michael Platten,et al. Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β , 2001, Journal of Neuro-Oncology.
[27] Werner Paulus,et al. Microglia promote glioma migration , 2002, Acta Neuropathologica.
[28] Martine M. Mirrione,et al. Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice , 2010, Neurobiology of Disease.
[29] J. Lafuente,et al. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-β (PDGFR-β) in human gliomas , 1999, Journal of Molecular Neuroscience.
[30] B. Badie,et al. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas , 2002, Journal of Neuroimmunology.
[31] W. Hickey,et al. Contents , 2004, Journal of Neuro-Oncology.
[32] P. Allavena,et al. Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation , 2009, Journal of leukocyte biology.
[33] J. Julien,et al. Increased glioma growth in mice depleted of macrophages. , 2007, Cancer research.
[34] G. Gromo,et al. The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro , 1994, Infection and immunity.
[35] S. Goswami,et al. Interleukin‐6‐Mediated Autocrine Growth Promotion in Human Glioblastoma Multiforme Cell Line U87MG , 1998, Journal of neurochemistry.
[36] Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis , 2007, BMC immunology.
[37] T. Roszman,et al. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. , 1997, Journal of immunology.
[38] S. Tsirka,et al. Tuftsin Fragment 1–3 Is Beneficial When Delivered After the Induction of Intracerebral Hemorrhage , 2005, Stroke.
[39] A. Barnekow,et al. Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor , 1998, Journal of Neuro-Oncology.
[40] A. Wesołowska,et al. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. , 2008, Oncogene.
[41] A. Cerwenka,et al. Regulatory T cells control macrophage accumulation and activation in lymphoma , 2009, International journal of cancer.
[42] David J. Yang,et al. Innate immune functions of microglia isolated from human glioma patients , 2006, Journal of Translational Medicine.
[43] Y. Fukuuchi,et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. , 1998, Brain research. Molecular brain research.
[44] E F Heineman,et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. , 1999, Journal of the National Cancer Institute.
[45] W. Roggendorf,et al. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study , 2001, Acta Neuropathologica.
[46] Michael E. Berens,et al. Molecular Mechanisms of Glioma Cell Migration and Invasion , 2004, Journal of Neuro-Oncology.
[47] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[48] C. Wood,et al. Expression of interleukin-11 and its encoding mRNA by glioblastoma cells , 1995, Neuroscience Letters.
[49] J. Tonn,et al. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. , 1997, Anticancer research.
[50] B. Scheithauer,et al. Microglia in brain tumors , 2002, Glia.
[51] H. Budka,et al. Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation , 2004, Acta Neuropathologica.
[52] J. Lafuente,et al. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. , 1999, Journal of molecular neuroscience : MN.
[53] W. Streit,et al. Reactive microgliosis , 1999, Progress in Neurobiology.
[54] L. D.,et al. Brain tumors , 2005, Psychiatric Quarterly.
[55] V. Najjar,et al. The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties. , 1973, Biochimica et biophysica acta.
[56] K. Frei,et al. Microglia and tumor rejection. , 1994, Neuropathology and applied neurobiology.
[57] Linet,et al. RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality. , 1999, Journal of the National Cancer Institute.
[58] W. Hiddemann,et al. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. , 1999, Experimental hematology.
[59] B. Becher,et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.
[60] B. Badie,et al. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.
[61] R. Weichselbaum,et al. Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. , 2010, Cancer research.
[62] R. Alterman,et al. Colony stimulating factor-1 expression in human glioma , 1994, Molecular and chemical neuropathology.
[63] H. Boddeke,et al. Vesicle-Mediated Transport and Release of CCL21 in Endangered Neurons: A Possible Explanation for Microglia Activation Remote from a Primary Lesion , 2005, The Journal of Neuroscience.
[64] W. Paulus,et al. Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.
[65] C. Beaudry,et al. MAP-ing glioma invasion: Mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival , 2007, Molecular Cancer Therapeutics.
[66] P. Rieckmann,et al. Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.
[67] S. Leung,et al. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.
[68] W. Hamel,et al. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model , 2010, Cancer Immunology, Immunotherapy.
[69] D. Mitchell,et al. Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens , 1992, Brain Research.
[70] Melody A. Swartz,et al. Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21 , 2010, Science.
[71] Nico van Rooijen,et al. Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.
[72] K. Stocka,et al. Gliomas induce and exploit microglial MT 1-MMP expression for tumor expansion , 2009 .
[73] A. Sonabend,et al. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors , 2006, Glia.
[74] G. Gillespie,et al. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. , 1995, Journal of Neurosurgery.